Roivant Sciences Statistics

Share Statistics

Roivant Sciences has 679.81M shares outstanding. The number of shares has increased by -3.41% in one year.

Shares Outstanding Shares Outstanding n/a Close	679.81M
Shares Change (YoY) Shares Change (YoY) n/a Close	-3.41%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-1.98%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	77.82%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	139
FTD / Avg. Volume FTD / Avg. Volume n/a Close	n/a

Short Selling Information

The latest short interest is 49.23M, so 6.9% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	49.23M
Short % of Shares Out Short % of Shares Out n/a Close	6.9%
Short % of Float Short % of Float n/a Close	9.26%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	8.53

Valuation Ratios

The PE ratio is 1.88 and the forward PE ratio is -9.59. Roivant Sciences's PEG ratio is 0.

PE Ratio PE Ratio n/a Close	1.88
Forward PE Forward PE n/a Close	-9.59
PS Ratio PS Ratio n/a Close	65.46
Forward PS Forward PS n/a Close	3.2
PB Ratio PB Ratio n/a Close	1.37
P/FCF Ratio P/FCF Ratio n/a Close	-10.66
PEG Ratio PEG Ratio n/a Close	0

Financial Ratio History

Enterprise Valuation

Roivant Sciences has an Enterprise Value (EV) of 2.13B.

EV / Sales EV / Sales n/a Close	17.09
EV / EBITDA EV / EBITDA n/a Close	0.49
EV / EBIT EV / EBIT n/a Close	-2.79
EV / FCF EV / FCF n/a Close	-2.78

Financial Position

The company has a current ratio of 25.24, with a Debt / Equity ratio of 0.08.

Current Ratio Current Ratio n/a Close	25.24
Quick Ratio Quick Ratio n/a Close	25.1
Debt / Equity Debt / Equity n/a Close	0.08
Debt / EBITDA Debt / EBITDA n/a Close	0.12
Debt / FCF Debt / FCF n/a Close	-0.65
Interest Coverage Interest Coverage n/a Close	121.97

Financial Efficiency

Return on Equity is 72.86% and Return on Invested Capital is 60.48%.

Return on Equity Return on Equity n/a Close	72.86%
Return on Assets Return on Assets n/a Close	60.21%
Return on Invested Capital Return on Invested Capital n/a Close	60.48%
Revenue Per Employee Revenue Per Employee n/a Close	$137,439.43
Profits Per Employee Profits Per Employee n/a Close	$4,789,566.08
Employee Count Employee Count n/a Close	908
Asset Turnover Asset Turnover n/a Close	0.02
Inventory Turnover Inventory Turnover n/a Close	0.79

Taxes

Income Tax Income Tax n/a Close	22.22M
Effective Tax Rate Effective Tax Rate n/a Close	0.52%

Stock Price Statistics

The stock price has increased by 5.46% in the last 52 weeks. The beta is 1.16, so Roivant Sciences's price volatility has been higher than the market average.

Beta Beta n/a Close	1.16
52-Week Price Change 52-Week Price Change n/a Close	5.46%
50-Day Moving Average 50-Day Moving Average n/a Close	10.64
200-Day Moving Average 200-Day Moving Average n/a Close	11.27
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	55.83
Average Volume (20 Days) Average Volume (20 Days) n/a Close	6,622,342

Income Statement

In the last 12 months, Roivant Sciences had revenue of 124.8M and earned 4.35B in profits. Earnings per share was 5.55.

Revenue Revenue n/a Close	124.8M
Gross Profit Gross Profit n/a Close	96.83M
Operating Income Operating Income n/a Close	4.24B
Net Income Net Income n/a Close	4.35B
EBITDA EBITDA n/a Close	4.31B
EBIT EBIT n/a Close	4.29B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	5.55

Full Income Statement

Balance Sheet

The company has 6.54B in cash and 499.75M in debt, giving a net cash position of 6.04B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	6.54B
Total Debt Total Debt n/a Close	499.75M
Net Cash Net Cash n/a Close	6.04B
Retained Earnings Retained Earnings n/a Close	576.17M
Total Assets Total Assets n/a Close	5.79B
Working Capital Working Capital n/a Close	5.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -765.27M and capital expenditures -1.38M, giving a free cash flow of -766.65M.

Operating Cash Flow Operating Cash Flow n/a Close	-765.27M
Capital Expenditures Capital Expenditures n/a Close	-1.38M
Free Cash Flow Free Cash Flow n/a Close	-766.65M
FCF Per Share FCF Per Share n/a Close	-0.98

Full Cash Flow Statement

Margins

Gross margin is 77.59%, with operating and profit margins of 3399.19% and 3484.86%.

Gross Margin Gross Margin n/a Close	77.59%
Operating Margin Operating Margin n/a Close	3399.19%
Pretax Margin Pretax Margin n/a Close	3408.33%
Profit Margin Profit Margin n/a Close	3484.86%
EBITDA Margin EBITDA Margin n/a Close	3453.86%
EBIT Margin EBIT Margin n/a Close	3399.19%
FCF Margin FCF Margin n/a Close	-614.33%

Dividends & Yields

ROIV does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	53.24%
FCF Yield FCF Yield n/a Close	-9.38%

Dividend Details

Analyst Forecast

The average price target for ROIV is $18, which is 60.7% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$18
Price Target Difference Price Target Difference n/a Close	60.7%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$27.75
Lynch Upside Lynch Upside n/a Close	147.77%
Graham Number Graham Number n/a Close	30.85
Graham Upside Graham Upside n/a Close	175.45%

Scores

Altman Z-Score Altman Z-Score n/a Close	22.6
Piotroski F-Score Piotroski F-Score n/a Close	4

Roivant Sciences Ltd. (ROIV)